An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques.
about
Continued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infectionInterferon for people with lamivudine-resistant chronic hepatitis B virus infectionAdefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infectionLamivudine during pregnancy for preventing hepatitis B virus infection in newbornsAntiviral treatments for lamivudine-resistant chronic hepatitis B adult patientsLamivudine for chronic hepatitis B in adultsAdvances in Molecular Diagnosis of HBV Infection and Drug ResistanceReview of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog TherapyStandardization of NAT for Blood-Borne PathogensManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesResistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxilNuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays.Treatment outcomes of clevudine versus lamivudine at week 48 in naïve patients with HBeAg positive chronic hepatitis B.Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNAInternational standards and reference materials for quantitative molecular infectious disease testing.Simultaneous visual detection of multiple viral amplicons by dipstick assay.Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy.Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.Diagnostic strategy for occult hepatitis B virus infection.Nucleic acid amplification technology methods used in blood donor screening.NAT screening of blood and plasma donations: evolution of technology and regulatory policy.Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G.Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virusUltra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.Comparison of currently available assays for detection of hepatitis B virus DNA in the routine diagnostic laboratory.Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infectionsApplication of molecular diagnostic techniques for viral testing.New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.Hepatitis B virus blood screening: unfinished agendas.Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantificationEfficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil.Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays.Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays.Management of chronic hepatitis B: consensus guidelinesMolecular testing in the diagnosis and management of chronic hepatitis BDevelopment and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis.Medical virology of hepatitis B: how it began and where we are now
P2860
Q24185958-17C08568-CD13-4E63-8F97-2FB5361EA1AAQ24185973-82495B9A-1F4D-4F9A-9E22-CBF3118DC01DQ24187530-A4BA2D84-D52A-48EC-9FD2-3E88B2178DD4Q24235720-1CD2709C-7686-4CB8-936E-1068E55A94B2Q24241469-917D2B36-93E8-4C0E-97CB-4E6A340DA344Q24246121-5BFDD16E-2F9D-4E57-A7FE-FB6A0EEDD0F2Q24810144-EC15D7E4-526E-44ED-9C63-4A6ABD8EF81BQ26740161-AD28F3D7-708D-43A4-93F8-DCC366C3EFE9Q26777738-59122D13-D337-404E-B1E5-E10CBE091DECQ27000080-9B11D2FE-903D-4317-B23C-251D06837036Q33233245-8B6929F9-D677-49D8-A1D0-FD631CA13CE8Q33578591-0524F982-2D91-4D58-AD67-66E1BA81EA9BQ33807256-9134B165-6EAC-4818-92C5-FB54297915ECQ33825842-3CC55585-FC3E-452E-9722-32CADFAB992AQ33856184-DAF7BD3A-FED6-4BBE-A4ED-11C4474CFAB5Q34041871-03CE6737-034D-4940-9FEA-479AC70BD73CQ34079748-FEFD9A14-E814-4D5A-8579-FF1179C329D3Q34303163-8893D289-5FAD-4124-8127-811FDED18385Q34430779-BB508166-3237-47F6-93C3-3B3860FAA080Q34569230-51BAA1DF-420B-4A7F-8AB5-63DB9E98E400Q34757381-BC250C05-7CBE-43B2-8540-9C408D598980Q34830170-0AA28722-23FE-45E8-BD43-E40F0C7D5CA8Q34996023-09E7A5A5-BBAD-45EA-82D5-A90FA25D755CQ35073340-7D85CBFF-BFA1-4EB3-9E14-106E8DBF40E3Q35802832-AF42272E-FA34-4C8C-A044-F975B01F07B6Q35964704-29428347-2DA7-4691-976F-3400E9196347Q36050544-48BE5AA5-DE33-47A7-A1D1-3BCA7A2DC30CQ36192699-4F6CE2BE-1305-4082-B795-2D9BD4A883D3Q36314573-B1311A09-0090-4496-95F8-3D289DA8A80DQ36466002-520E808A-F1CF-49E9-9AD5-D2845A7BA58DQ36466447-6F2209EE-B872-4CA5-ABAE-79A442727F9EQ36498410-13136DFD-8D82-4B6D-A9B7-59E03FC5245DQ36673025-A809A4AB-E9EB-4493-B653-4FFE2390DFEBQ36793870-EE824D83-4A1E-4238-A837-AE22B0623453Q36841543-9BBA1DA8-0EC4-4CD9-B176-59A01DFB15E9Q36845374-4D1C4E8A-075A-41AB-B337-47CFD54E127CQ36849343-5477BB98-FE6F-48B9-B22B-F523DC42512EQ36881140-3C70921A-13C5-470F-8176-0D47975AEBF7Q36971159-5D7A1FBE-755C-44A3-8748-C3BAB2ADE183Q37059714-7D37AAC2-E365-470B-B54E-745498E2AD19
P2860
An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
An international collaborative ...... acid amplification techniques.
@en
An international collaborative ...... acid amplification techniques.
@nl
type
label
An international collaborative ...... acid amplification techniques.
@en
An international collaborative ...... acid amplification techniques.
@nl
prefLabel
An international collaborative ...... acid amplification techniques.
@en
An international collaborative ...... acid amplification techniques.
@nl
P2093
P2860
P1433
P1476
An international collaborative ...... acid amplification techniques.
@en
P2093
J Saldanha
K Heermann
WHO Collaborative Study Group
P2860
P356
10.1046/J.1423-0410.2001.00003.X
P577
2001-01-01T00:00:00Z